INDRAMEDCO vs RAINBOW: Stock Comparison
RAINBOW CHILDRENS MED is the larger company by market capitalisation. INDRAPRASTHA MEDICAL CORP shows a lower P/E, a higher ROE and a higher dividend yield, while RAINBOW CHILDRENS MED shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
INDRAMEDCO leads 7; RAINBOW leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | INDRAMEDCO | RAINBOW |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Hospital | Hospital |
Price
| Metric | INDRAMEDCO | RAINBOW |
|---|---|---|
| Live Price | ₹308.2 | ₹1,192.9 |
| Day Change | -3.17% | -0.33% |
| Volume | 37,936 | 38,084 |
| 52-Week High | ₹640.85 | ₹1,610 |
| 52-Week Low | ₹293.65 | ₹1,084 |
| Distance from 52W High | -51.91% | -25.91% |
Valuation
| Metric | INDRAMEDCO | RAINBOW |
|---|---|---|
| Market Cap | ₹2,827 Cr | ₹12,118 Cr |
| P/E Ratio | 15.51x | 42.63x |
| P/B Ratio | 3.94x | 7.38x |
| EPS | ₹20.51 | ₹5.96 |
| Book Value | ₹80.78 | ₹163.8 |
| Dividend Yield | 1.28% | 0.29% |
Growth
| Metric | INDRAMEDCO | RAINBOW |
|---|---|---|
| Revenue Growth (TTM YoY) | 9.3% | 24.3% |
| EPS Growth (TTM YoY) | 1.8% | 39.1% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | INDRAMEDCO | RAINBOW |
|---|---|---|
| ROE | 24.8% | 14.8% |
| ROCE | 25.58% | 17.99% |
| Net Margin | 12.21% | 16.34% |
| Operating Margin | 17% | 26.24% |
| Debt to Equity | 0x | 0.01x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | INDRAMEDCO | RAINBOW |
|---|---|---|
| Promoter Holding | 49.39% | 49.83%▼ 0.01 pp |
| FII Holding | 2.39%▼ 0.38 pp | 14.66%▼ 1.37 pp |
| DII Holding | 1.77%▲ 1.18 pp | 23.28%▲ 0.72 pp |
| Public Holding | 44.84%▼ 0.8 pp | 11.83%▲ 0.44 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INDRAPRASTHA MEDICAL CORP and RAINBOW CHILDRENS MED.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.